ENTITY
Kindstar Globalgene Technology

Kindstar Globalgene Technology (9960 HK)

12
Analysis
Health Care • China
Kindstar Globalgene Technology is a leading independent medical testing provider in China, specializing in esoteric diagnostic testing services. The company offers a wide range of advanced specialty testing across hematology, genetic diseases, rare diseases, infectious diseases, oncology, neurology, and maternity-related testing, alongside scientific research services and CRO. It was founded in 2003 and is headquartered in Wuhan, Hubei, China.
more
•29 Jun 2021 00:44

Kindstar Globalgene IPO Initiation: Testing, Testing

Kindstar is set to launch an IPO to raise around $300 m. It has successfully overcome the COVID-19 pandemic. In combination, with operating...

Logo
467 Views
Share
•28 Jun 2021 17:25

Kindstar Globalgene (åŗ·åœ£ēŽÆēƒ) Pre-IPO: Financial and Valuation Update

We looked at the latest post-hearing prospectus filed by Kindstar, updated our forecast and valuation for the company. Market sentiment for the...

Logo
525 Views
Share
•06 Apr 2021 09:10

Pre-IPO Kindstar Globalgene Technology - A New Start with More Challenges

This article included insights onĀ Kindstar Globalgene Technology in terms of business analysis, financial analysis, and the concerns and future...

Logo
481 Views
Share
bullish•Zhihu Technology
•28 Mar 2021 09:05

ECM Weekly (28th March 2021) - Bairong, Bilibili HK, Linklogis, Energy Monster, Zhihu, Monde Nissin

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
•25 Mar 2021 16:09

Kindstar (åŗ·åœ£ēŽÆēƒ) Pre-IPO: Is It Worth the Premium?

We compare the company's key financial metrics with other leading listed ICL. We also discuss the company's pre-IPO valuation in the context of its...

Logo
1.1k Views
Share
x